About | HeinOnline Law Journal Library | HeinOnline Law Journal Library | HeinOnline

1 1 (November 28, 2023)

handle is hein.crs/govennw0001 and id is 1 raw text is: 







              Congressional_______
                Research Service






Kratom Regulation: Federal Status and State

Approaches



November 28, 2023

Kratom, orMitragyna speciosa, is a tree related to the coffee plant and is native to parts of Southeast
Asia. Peoples indigenous to the tree's range have traditionally consumed the leaves of the tree for
medicinal and other purposes. Users report both stimulant and sedative effects, believed to be caused by
two compounds in the leaves, mitragynine and 7-hydroxymitragynine. Some commentators have raised
safety concerns over kratom use, while others have suggested various beneficial uses. Additionally, some
kratom products intended for sale in the United States have been found to contain dangerous
contaminants, such as salmonella and heavy metals.
Kratom use in the United States has reportedly become more widespread in the past decade, and its
regulatory status has been a matter of recent debate. This Sidebar begins by reviewing federal
administrative actions relating to kratom before summarizing kratom-focused bills introduced in the
current Congress. The Sidebar then describes the various approaches taken by 22 states that have
regulated or banned kratom, which may be instructive as Congress considers action on kratom.


Executive Branch Actions

The Controlled Substances Act (CSA) creates the federal framework for regulating drugs and other
substances deemed to pose a risk of abuse and dependence. The CSA divides controlled substances into
five numbered lists, known as Schedules IV, with Schedule I status imposing the most stringent
restrictions. Congress may modify these schedules through legislation. Congress has also delegated
authority to the Drug Enforcement Administration (DEA) to schedule, reschedule, or deschedule
substances under the CSA through regulation.
In 2016, DEA published notice of its intent to place mitragynine and 7-hydroxymitragynine in Schedule I
on an emergency basis, which would have criminalized possession of kratom and made distribution a
felony. However, after receiving numerous comments from some Members of Congress, advocacy
groups, and others, DEA withdrew that notice. DEA has listed kratom as a Drug and Chemical of Concern
but to date has not exercised its authority to schedule kratom or its active compounds under the CSA.
Under the Federal Food, Drug, and Cosmetic Act (FD&C Act), as amended, the Food and Drug
Administration (FDA) may regulate drugs and dietary supplements sold in the United States. FDA has
                                                                Congressional Research Service
                                                                https://crsreports.congress.gov
                                                                                    LSB11082

CRS Legal Sidebar
Prepared for Members and
Committees of Congress

What Is HeinOnline?

HeinOnline is a subscription-based resource containing thousands of academic and legal journals from inception; complete coverage of government documents such as U.S. Statutes at Large, U.S. Code, Federal Register, Code of Federal Regulations, U.S. Reports, and much more. Documents are image-based, fully searchable PDFs with the authority of print combined with the accessibility of a user-friendly and powerful database. For more information, request a quote or trial for your organization below.



Short-term subscription options include 24 hours, 48 hours, or 1 week to HeinOnline.

Contact us for annual subscription options:

Already a HeinOnline Subscriber?

profiles profiles most